-- Lupin's (NSE:LUPIN, BOM:500257) consolidated attributable profit rose sharply to 14.6 billion Indian rupees in the fiscal fourth quarter ended March 31, from 7.73 billion rupees. a year ago.
Earnings per share came in at 31.89 rupees from 16.87 rupees a year earlier, the pharmaceutical company said in a filing with the Indian stock exchanges on Thursday.
Revenue from operations in fiscal Q4 increased to 74.7 billion rupees from 56.7 billion rupees a year ago.
The company's board declares a dividend of 18 rupees per equity share of face value of 2 rupees each, fully paid up, for the financial year ended March 31.